| Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference? | |
| | |
MedLine Citation:
|
PMID: 19432614 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Women seeking termination of pregnancy in Auckland, New Zealand can chose between medical and surgical options up to eight weeks gestation. AIMS: To assess demographic differences or changes over time between proportions of women choosing medical or surgical abortions at a single centre and determine whether changing the mifepristone-misoprostol interval from two to one day impacted on outcomes. METHODS: Retrospective audit of two consecutive years (December 2005-November 2006 and December 2006-November 2007) of first-trimester surgical and medical terminations where the mifepristone-misoprostol interval was reduced from two to one day between years. Analysis using descriptive statistics and assessment of probability of observed differences between groups. RESULTS: A total of 1495 terminations were performed in 2005-2006 and 1588 in 2006-2007. No significant difference (P = 0.4) of eligible women choosing medical (21% and 23%) or surgical abortion between years. Ethnicity, age and residency status did not influence choice. Medical termination of pregnancy was more likely in women who were without previous children (P = 0.009), pregnancies (P = 0.02) or terminations (P = 0.04). Medical termination was similarly effective within six hours with either two- or one-day intervals. CONCLUSIONS: Both medical and surgical first-trimester abortions are safe and effective. It is optimal to be able to offer women choice. Reducing the medical interval to one day does not increase adverse outcomes. |
| | |
Authors:
|
Felicity Goodyear-Smith; Alison Knowles |
Related Documents
:
|
1766444 - Judging social issues: difficulties, inconsistencies, and consistencies. 10457864 - Misoprostol used alone for the termination of early pregnancy. a review of the evidence. 11809024 - Freud's struggle with misogyny: homosexuality and guilt in the dream of irma's injection. 14518484 - Idealists or pragmatists? progressives and separatists among australian medical women, ... 9876704 - Hans frangenheim--culdoscopy vs. laparoscopy, the first book on gynecological endoscopy... 17149984 - Profiling in basketball: physical and physiological characteristics of elite players. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Australian & New Zealand journal of obstetrics & gynaecology Volume: 49 ISSN: 1479-828X ISO Abbreviation: Aust N Z J Obstet Gynaecol Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-05-12 Completed Date: 2009-08-03 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0001027 Medline TA: Aust N Z J Obstet Gynaecol Country: Australia |
Other Details:
|
Languages: eng Pagination: 211-5 Citation Subset: IM |
Affiliation:
|
Department of General Practice and Primary Health Care, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. f.goodyear-smith@auckland.ac.nz |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents
/
administration & dosage Abortion, Induced / methods*, psychology* Adult Choice Behavior* Drug Administration Schedule Drug Therapy, Combination Female Gravidity Humans Mifepristone / administration & dosage Misoprostol / administration & dosage New Zealand Patient Participation* Pregnancy Pregnancy Trimester, First Retrospective Studies Vacuum Curettage Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone |
| Comments/Corrections | |
Comment In:
|
Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):564
[PMID:
19780750
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of three management strategies for patients with atypical squamous cells of undetermined ...
Next Document: Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.